Soleno Therapeutics (SLNO) Current Assets: 2013-2018
Historic Current Assets for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2018 value amounting to $24.7 million.
- Soleno Therapeutics' Current Assets rose 1.72% to $11.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $11.6 million, marking a year-over-year increase of 1.72%. This contributed to the annual value of $24.7 million for FY2018, which is 37.10% up from last year.
- Latest data reveals that Soleno Therapeutics reported Current Assets of $24.7 million as of FY2018, which was up 37.10% from $18.0 million recorded in FY2017.
- Over the past 5 years, Soleno Therapeutics' Current Assets peaked at $24.7 million during FY2018, and registered a low of $3.8 million during FY2016.
- For the 3-year period, Soleno Therapeutics' Current Assets averaged around $15.5 million, with its median value being $18.0 million (2017).
- Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 447.30% in 2014, then tumbled by 40.64% in 2016.
- Yearly analysis of 5 years shows Soleno Therapeutics' Current Assets stood at $8.3 million in 2014, then decreased by 23.19% to $6.4 million in 2015, then slumped by 40.64% to $3.8 million in 2016, then soared by 373.37% to $18.0 million in 2017, then spiked by 37.10% to $24.7 million in 2018.